This recall was expanded on January 29, 2019. This recall affects products that have expired during 2019. There have been no other ibuprofen recalls since January 2019, according to the FDA. The article has been corrected to reflect this information.
(WTNH) — New Jersey-based pharmaceutical company, Tris Pharma Inc., has expanded its voluntary recall of its infants’ liquid ibuprofen after discovering higher concentrations of the medication in some packages.
The company added three additional lots of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL, to the retail (pharmacy) level.
The FDA reports infants already susceptible to the adverse effects of ibuprofen may be slightly higher at risk if they receive medication from an impacted bottle.
There is also the remote probability that infants, who may be more susceptible to a higher potency level of drug, may be more vulnerable to permanent NSAID-associated renal injury.
Altogether, the company has recalled six lots of the medicine and found that they contained 10% more ibuprofen than the specified limit.
The impacted items were sold at Walmart, CVS, and Family Dollar.
The products should not be used but thrown out or brought to the store where it was purchased from for a full refund.
- Washington DC one step closer to becoming a state as House passes bill
- CDC investigating Oregon woman’s death after J&J vaccine
- Pennsylvania man accused of stalking woman with tracking device
- Crew-2 launch: When and how to watch NASA, SpaceX send crewed mission to ISS Friday
- Panel: End commanders’ power to block military sex cases